This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Amura Therapeutics Limited, Amura Limited. Active years: 2011-2015.
Location History:
- Madingley, GB (2011 - 2013)
- Cambridge, GB (2015)
Company Filing History:
Years Active: 2011-2015
Title: Innovations of Nicholas Sean Flinn
Introduction
Nicholas Sean Flinn is a notable inventor based in Madingley, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target human cathepsin S. With a total of 4 patents to his name, Flinn's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Flinn's latest patents involves Furo[3, 2-B] pyrrol-3-ones as cathepsin S inhibitors. This invention relates to a compound of formula (I), or a pharmaceutically acceptable salt, hydrate, complex, or pro-drug thereof. Compounds of formula (I) exhibit surprisingly high efficacies for human cathepsin S and excellent selectivity versus other mammalian cathepsins. These compounds are useful for the treatment of diseases such as rheumatoid arthritis, multiple sclerosis, myasthenia gravis, transplant rejection, diabetes, Sjögren's syndrome, Grave's disease, systemic lupus erythematosus, osteoarthritis, psoriasis, idiopathic thrombocytopenic purpura, allergic rhinitis, asthma, atherosclerosis, obesity, chronic obstructive pulmonary disease, and chronic pain.
Career Highlights
Flinn has worked with several companies throughout his career, including Amura Therapeutics Limited and Amura Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of Flinn's notable coworkers include Martin Quibell and John Paul Watts. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Nicholas Sean Flinn is a distinguished inventor whose work in developing cathepsin S inhibitors showcases his commitment to advancing medical science. His contributions have the potential to improve the lives of many individuals suffering from chronic diseases.